We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 600 increasing their positions, 700 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

4% more funds holding in top 10

Funds holding in top 10: 140146 (+6)

2% more call options, than puts

Call options by funds: $988M | Put options by funds: $966M

0% less capital invested

Capital invested by funds: $126B → $126B (-$45.9M)

0% less funds holding

Funds holding: 1,6211,619 (-2)

0.99% less ownership

Funds ownership: 74.67%73.67% (-0.99%)

14% less repeat investments, than reductions

Existing positions increased: 600 | Existing positions reduced: 700

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.86%
Holding in Top 10
146
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+4.29%
% of All Funds
4.23%
New
65
Increased
600
Reduced
700
Closed
53
Calls
$988M
Puts
$966M
Net Calls
+$21.2M
Net Calls Change
-$81.3M

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.04% from $126B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 600 added to existing stakes and 700 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.04% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.